Presidential candidates aren’t talking about drug shortages. They should be
(By Patrick Skerrett for STAT) In the conclusion of her recently published book, “Bottle of Lies,” Katherine Eban briefly notes
Read moreFDA
Novartis was aware of manipulation of data supporting gene therapy approval, FDA says
(By Adam Feuerstein for STAT) AveXis, the gene therapy subsidiary of Swiss pharma giant Novartis (NVS), was aware of “data
Read moreTrump Administration ‘Open For Business’ On Drug Imports From Canada
(By Phil Galewitz for Kaiser Health News) A year after calling proposals allowing Americans to import cheaper drugs from Canada
Read moreFDA approves Rituxan biosimilar
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune
Read moreFDA approves 1st Lyrica generics
(By Alia Paavola for Becker’s Hospital Review) The FDA has approved several new generics of Lyrica, a brand-name drug manufactured by Pfizer
Read moreDrugmaker tried to shred records before FDA inspection, agency claims
(By Alia Paavola for Becker’s Hospital Review) FDA inspectors claim that Strides Pharma Science, an India-based drugmaker that sells numerous
Read morePatient dies from fecal transplant, FDA warns
(By Alia Paavola for Becker’s Hospital Review) The FDA alerted healthcare providers June 13 that at least one patient has died after
Read moreTeva expands nationwide recall of losartan
(By Alia Paavola for Becker’s Hospital Review) Teva Pharmaceuticals has recalled an additional six lots of bulk losartan potassium tablets,
Read moreFed up with Washington, ALS advocates consider ACT UP’s take-no-prisoners approach
(By Nicholas Florko for STAT) WASHINGTON — Next Wednesday, a cadre of ALS patients will gather for a protest outside
Read moreCancer Drugs Approved Quickly Often Fail To Measure Up Later
(By Richard Harris for NPR) Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show
Read more